title: An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.
abstract: The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases," held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to four previous biennial conferences held at the University of Vermont in 2005, 2007, 2009, and 2011. Each of those conferences, also sponsored by the National Institutes of Health, American Thoracic Society, and Respiratory Disease Foundations, has been important in helping guide research and funding priorities. The major conference recommendations are summarized at the end of the report and highlight both the significant progress and major challenges in these rapidly progressing fields.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Weiss
authors.forename: Daniel
authors.initials: D
authors.lastname: Chambers
authors.forename: Adam
authors.initials: A
authors.lastname: Giangreco
authors.forename: Armand
authors.initials: A
authors.lastname: Keating
authors.forename: Darrell
authors.initials: D
authors.lastname: Kotton
authors.forename: Peter I
authors.initials: PI
authors.lastname: Lelkes
authors.forename: Darcy E
authors.initials: DE
authors.lastname: Wagner
authors.forename: Darwin J
authors.initials: DJ
authors.lastname: Prockop
mesh_terms: D064987:Cell- and Tissue-Based Therapy; D053595:Embryonic Stem Cells / Q000166:cytology / Q000502:physiology; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology / Q000502:physiology; D008168:Lung / Q000166:cytology / Q000502:physiology*; D008171:Lung Diseases / Q000628:therapy*; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000502:physiology; D054555:National Heart, Lung, and Blood Institute (U.S.); D012955:Societies, Medical; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology / Q000502:physiology*; D023822:Tissue Engineering; D014133:Tracheal Diseases / Q000628:therapy*; D014481:United States